Document is current
Any future updates will be listed below
-
Authors
Biswas, Dhruva
Aminorroaya, Arya
Croon, Philip M.
Batinica, Bruno
Pedroso, Aline F.
Khera, Rohan
-
Funding
Funding for this research was provided by:
National Institutes of Health (R01AG089981, R01HL167858, and K23HL153775)
Doris Duke Charitable Foundation (2022060)
- License Information
-
More Information
Article History
Received: 7 August 2025
Accepted: 13 August 2025
First Online: 1 September 2025
Declarations
:
: No animal or human subjects by the authors were used in this study.
: DB is a co-inventor on US patent applications 2025/0084489 and 2022/0136063. PMC is a former founder and shareholder of DGTL Health B.V. and currently receives consultancy fees from the company. RK is an Associate Editor of JAMA. He receives research support through Yale from Bristol-Myers Squibb, Novo Nordisk, BridgeBio, and the Blavatnik Family Foundation. He is a co-inventor of US Provisional Patent Applications WO2023230345A1, US20220336048A1, 63/346,610, 63/484,426, 63/508,315, 63/580,137, 63/606,203, 63/619,241, 63/562,335 and 18/813,882, all unrelated to the current work. RK is a co-founder of Evidence2Health, a precision health platform to improve evidence-based cardiovascular care. RK is an academic co-founder of Ensight-AI, Inc., an AI-ECG analytics company. All other authors declare no relevant competing interests.
